One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review

ABSTRACT: Staphylococcus aureus bacteraemia (SAB) is often a complication of injecting drug use, and is associated with high morbidity and mortality. This article reports the first audit of inpatient parenteral treatment of SAB completion among people who inject drugs (PWID) in Australia. Of 198 pat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liam S. Acheson, Krista J. Siefried, Brendan Clifford, Emily Murray, Maureen Steele, Liesa Clague, Victoria Malone, Darren M. Roberts, Lisa-Jayne Ferguson, Gail V. Matthews, Nadine Ezard
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Staphylococcus aureus bacteraemia People who inject drugs Healthcare services Infectious diseases Drug dependence Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/2de56c0bda794b86bd7a8456303f6986
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2de56c0bda794b86bd7a8456303f6986
record_format	dspace
spelling	oai:doaj.org-article:2de56c0bda794b86bd7a8456303f69862021-11-30T04:14:09ZOne-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review1201-971210.1016/j.ijid.2021.09.012https://doaj.org/article/2de56c0bda794b86bd7a8456303f69862021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221007207https://doaj.org/toc/1201-9712ABSTRACT: Staphylococcus aureus bacteraemia (SAB) is often a complication of injecting drug use, and is associated with high morbidity and mortality. This article reports the first audit of inpatient parenteral treatment of SAB completion among people who inject drugs (PWID) in Australia. Of 198 patients admitted with SAB, 106 were analysed. Twelve PWID had an inpatient stay <14 days compared with seven non-PWID (34% vs 10%; P=0.002). Sixteen PWID experienced discharge against medical advice compared with zero non-PWID (46% vs 0%; P<0.001). Re-admission to hospital within 28 days was 2.5 times greater among PWID than non-PWID (31% vs 15%; P=0.026). Methadone dose <60 mg/day was associated with premature discharge in opioid-dependent PWID receiving methadone (n=21, 100% vs 31%; P=0.012).Liam S. AchesonKrista J. SiefriedBrendan CliffordEmily MurrayMaureen SteeleLiesa ClagueVictoria MaloneDarren M. RobertsLisa-Jayne FergusonGail V. MatthewsNadine EzardElsevierarticleStaphylococcus aureus bacteraemiaPeople who inject drugsHealthcare servicesInfectious diseasesDrug dependenceInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 112, Iss , Pp 63-65 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Staphylococcus aureus bacteraemia People who inject drugs Healthcare services Infectious diseases Drug dependence Infectious and parasitic diseases RC109-216
spellingShingle	Staphylococcus aureus bacteraemia People who inject drugs Healthcare services Infectious diseases Drug dependence Infectious and parasitic diseases RC109-216 Liam S. Acheson Krista J. Siefried Brendan Clifford Emily Murray Maureen Steele Liesa Clague Victoria Malone Darren M. Roberts Lisa-Jayne Ferguson Gail V. Matthews Nadine Ezard One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
description	ABSTRACT: Staphylococcus aureus bacteraemia (SAB) is often a complication of injecting drug use, and is associated with high morbidity and mortality. This article reports the first audit of inpatient parenteral treatment of SAB completion among people who inject drugs (PWID) in Australia. Of 198 patients admitted with SAB, 106 were analysed. Twelve PWID had an inpatient stay <14 days compared with seven non-PWID (34% vs 10%; P=0.002). Sixteen PWID experienced discharge against medical advice compared with zero non-PWID (46% vs 0%; P<0.001). Re-admission to hospital within 28 days was 2.5 times greater among PWID than non-PWID (31% vs 15%; P=0.026). Methadone dose <60 mg/day was associated with premature discharge in opioid-dependent PWID receiving methadone (n=21, 100% vs 31%; P=0.012).
format	article
author	Liam S. Acheson Krista J. Siefried Brendan Clifford Emily Murray Maureen Steele Liesa Clague Victoria Malone Darren M. Roberts Lisa-Jayne Ferguson Gail V. Matthews Nadine Ezard
author_facet	Liam S. Acheson Krista J. Siefried Brendan Clifford Emily Murray Maureen Steele Liesa Clague Victoria Malone Darren M. Roberts Lisa-Jayne Ferguson Gail V. Matthews Nadine Ezard
author_sort	Liam S. Acheson
title	One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
title_short	One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
title_full	One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
title_fullStr	One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
title_full_unstemmed	One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
title_sort	one-third of people who inject drugs are at risk of incomplete treatment for staphylococcus aureus bacteraemia: a retrospective medical record review
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/2de56c0bda794b86bd7a8456303f6986
work_keys_str_mv	AT liamsacheson onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT kristajsiefried onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT brendanclifford onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT emilymurray onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT maureensteele onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT liesaclague onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT victoriamalone onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT darrenmroberts onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT lisajayneferguson onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT gailvmatthews onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview AT nadineezard onethirdofpeoplewhoinjectdrugsareatriskofincompletetreatmentforstaphylococcusaureusbacteraemiaaretrospectivemedicalrecordreview
_version_	1718406794173218816

One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review

Ejemplares similares